[20200121]R46189_美国食品和药物管理局（FDA）对大麻二酚（CBD）消费品的监管：大会概况和注意事项.pdf

FDA Regulation of Cannabidiol (CBD) Consumer Products: Overview and Considerations for Congress Agata Dabrowska, Coordinator Analyst in Health Policy Victoria R. Green Analyst in Health Policy Rene Johnson Specialist in Agricultural Policy Lisa N. Sacco Analyst in Illicit Drugs and Crime Policy January 21, 2020 Congressional Research Service 7-. www.crs.gov R46189